Clinical Trial Update: Synvisc Injections for Lumbar Facet Joint Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Synvisc injections for lumbar facet joint pain is underway, with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Facet Joint Pain

Drugs mentioned

• Synvisc (Hylan G-F 20)

Snippet

Sponsor: Sheltering Arms Physical Rehabilitation Hospitals | Conditions: Joint Pain | Phase 3 | Status: UNKNOWN